SILVER SPRING, Md., Sept. 30, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration have issued joint warning letters to four online networks, operating a total of 10 websites, illegally marketing unapproved and misbranded versions of opioid medicines, including tramadol, that are potentially dangerous. The warning l

STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- As previously communicated, Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company"), intends to propose the Annual General Meeting for the abbreviated financial year 2019 to resolve on a payment to the shareholders through redemption of shares. The Board of Directors has now set the proposed redemption amount to

SAN FRANCISCO, Sept. 30, 2019 /PRNewswire/ -- Today the Stupski Foundation announced its spend down strategies to addres

STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd for development, registration and commercialization of MOB-015 in Japan. Under the agreement, Moberg Pharma is eligible to receive milestones of up to USD 50 million

ENOLA, Pa., Sept. 30, 2019 /PRNewswire/ -- Post Acute Medical, LLC, (PAM) announced today it has acquired nine long-term acute care hospitals from LifeCare Holdings, which filed for bankruptcy in May. PAM will continue to employ many key staff members of LifeCare.

CHICAGO, Sept. 30, 2019 /PRNewswire/ -- Bright Pink, a national nonprofit organization focusing on the prevention of breast and ovarian cancer in women, is participating in Breast C

BARCELONA, Spain, Sept. 30, 2019 /PRNewswire/ -- The Alliance for Safe Biologic Medicines (ASBM) this week shared preliminary findings from a survey of 575 biologic prescribers in six Western European countries, covering several key policy issues including biosimilar substitution practices, adverse event reporting, and government tendering criteria. Since 201

LOS ANGELES, Sept. 30, 2019 /PRNewswire/ -- A California woman suffering from mesothelioma has prevailed in the latest talc trial against Johnson & Johnson, following six days of jury deliberation that ended Friday when the jury awarded her $40 million in damages.Nancy Cabibi, 71, of Hasuer,

ROSEMONT, Ill., Sept. 30, 2019 /PRNewswire/ -- The Arthroscopy Association

CHICAGO, Sept. 30, 2019 /PRNewswire/ -- Research in The Journal of the American Osteopathic Association found an association between sleep duration and obesity among African Americans. Although some populations are more susceptible to becoming overweight or obese, prior studies have not focused on minorities, the authors wrote.